Table 1.
Comparison of Seroprevalence IgG in European Countries
| Country, First Author |
No. of Participants |
Prevalence % | 95% CI | Date of Blood Test | Population Type |
|---|---|---|---|---|---|
| Belgium, Blairon6 | 1,494 | 1.6 | NA | May 25–June 19 | 4 public hospitals |
| Belgium, Martin7 | 326 | 11.0 | NA | April 15– May 18 | CHU Saint Pierre, Bruxels |
| UK, Bampoe3 | 200 | 14.5 | 9.9–20.1 | May 11–June 5 | Maternity, London |
| Germany, Korth2 | 316 | 1.6 | NA | March 25– April 21 | Essen Hospital, tertiary-care |
| Germany, Lackermair9 | 151 | 2.6 | 0.8–7.1 | April 2–6 | Outpatient center, Dachau |
| Germany, Schmidt1 | 385 | 2.9 | NA | April 20–30 | Neurologic clinic |
| Spain, Garcia-Basteiro4 | 578 | 7.6 | NA | March 28–April 9 | Hospital reference, Barcelona |
| Denmark, Iversen8 | 28,792 | 2.7 | 2.5–2.9 | April 15–23 | Capital region |
| France, Delmasa | 4,607 | 11.5 | 10.6–12.4 | May 14–June 17 | Paris Center, university hospital |
Note. CI, confidence interval.
a
Present study.